ESTEVE CDMO expands U.S. capacity with additional $17.5 million investment in Morton Grove

The Medical News · 2h ago

ESTEVE CDMO, a global pure-play CDMO specializing in the development and manufacture of small-molecule APIs and pharmaceutical intermediates, has approved an additional $17.5 million capacity expansion and containment capabilities at its Morton Grove, Illinois facility, bringing total announced investment at the site to $33 million.

Read original article on The Medical News →

ESTEVE CDMO expands U.S. capacity with additional $17.5 million investment in Morton Grove

Related news